Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Current Deferred Tax Assets (2021)

Historic Current Deferred Tax Assets for BioNexus Gene Lab (BGLC) over the last 1 years, with Q4 2021 value amounting to $67606.0.

  • BioNexus Gene Lab's Current Deferred Tax Assets changed N/A to $67606.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $67606.0, marking a year-over-year change of. This contributed to the annual value of $67606.0 for FY2021, which is N/A changed from last year.
  • Latest data reveals that BioNexus Gene Lab reported Current Deferred Tax Assets of $67606.0 as of Q4 2021.
  • BioNexus Gene Lab's 5-year Current Deferred Tax Assets high stood at $67606.0 for Q4 2021, and its period low was $67606.0 during Q4 2021.